trial

Social Isolation and Aging in Schizophrenia

NCTId NCT07419321
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Recruiting
Enrollment 650 (estimated)
Sponsored by Icahn School of Medicine at Mount Sinai
Primary completion 2026-07
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
650 (estimated)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2024-01-09
Primary completion
2026-07
Eligibility
ALL · 40 Years · 70 Years

Interventions & indications

Drugs
—

Sponsors

Icahn School of Medicine at Mount SinaiLead Sponsor
National Institute of Mental Health (NIMH)Collaborator
Yale UniversityCollaborator
Hartford HospitalCollaborator
Hospital General Universitario Gregorio MarañonCollaborator
Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)Collaborator
King's College LondonCollaborator
University of MiamiCollaborator
Boston Children's HospitalCollaborator
GGZ Noord-Holland-NoordCollaborator
Karolinska InstitutetCollaborator

Investigators

1
Abraham ReichenbergPrincipal Investigator

Sites

4 total
Hartford, United StatesAmsterdam, NetherlandsMadrid, SpainLondon, United Kingdom

Facts & assertions

4 sourced
Enrollment
650
Phase
NA
Primary Completion Date
2026-07
Status
RECRUITING
relationships
The graph out of here
lead_sponsor
Icahn School of Medicine at Mount Sinai
company
collaborator
National Institute of Mental Health (NIMH)
company
Yale University
company
indication
Schizophrenia and Related Disorders
indication
Schizophrenia
indication
Social Isolation
indication
investigator
Abraham Reichenberg
person